Gabriel Jiménez

Gabriel Jimenez, Daniel Racoceanu

Non-invasive brain imaging techniques allow understanding the behavior and macro changes in the brain to determine the progress of a disease. However, computational pathology provides a deeper understanding of brain disorders at cellular level, able to consolidate a diagnosis and make the bridge between the medical image and the omics analysis. In traditional histopathology, histology slides are visually inspected, under the microscope, by trained pathologists. This process is time-consuming and labor-intensive; therefore, the emergence of Computational Pathology has triggered great hope to ease this tedious task and make it more robust. This chapter focuses on understanding the state-of-the-art machine learning techniques used to analyze whole slide images within the context of brain disorders. We present a selective set of remarkable machine learning algorithms providing discriminative approaches and quality results on brain disorders. These methodologies are applied to different tasks, such as monitoring mechanisms contributing to disease progression and patient survival rates, analyzing morphological phenotypes for classification and quantitative assessment of disease, improving clinical care, diagnosing tumor specimens, and intraoperative interpretation. Thanks to the recent progress in machine learning algorithms for high-content image processing, computational pathology marks the rise of a new generation of medical discoveries and clinical protocols, including in brain disorders.

Yuning Huang, Jingchen Zou, Lanxi Meng et al.

Medical image analysis frequently encounters data scarcity challenges. Transfer learning has been effective in addressing this issue while conserving computational resources. The recent advent of foundational models like the DINOv2, which uses the vision transformer architecture, has opened new opportunities in the field and gathered significant interest. However, DINOv2's performance on clinical data still needs to be verified. In this paper, we performed a glioma grading task using three clinical modalities of brain MRI data. We compared the performance of various pre-trained deep learning models, including those based on ImageNet and DINOv2, in a transfer learning context. Our focus was on understanding the impact of the freezing mechanism on performance. We also validated our findings on three other types of public datasets: chest radiography, fundus radiography, and dermoscopy. Our findings indicate that in our clinical dataset, DINOv2's performance was not as strong as ImageNet-based pre-trained models, whereas in public datasets, DINOv2 generally outperformed other models, especially when using the frozen mechanism. Similar performance was observed with various sizes of DINOv2 models across different tasks. In summary, DINOv2 is viable for medical image classification tasks, particularly with data resembling natural images. However, its effectiveness may vary with data that significantly differs from natural images such as MRI. In addition, employing smaller versions of the model can be adequate for medical task, offering resource-saving benefits. Our codes are available at https://github.com/GuanghuiFU/medical_DINOv2_eval.

Chenxi Zhao, Jianqiang Li, Qing Zhao et al.

Alzheimer's Disease (AD) is a neurodegenerative disorder characterized by amyloid-beta plaques and tau neurofibrillary tangles, which serve as key histopathological features. The identification and segmentation of these lesions are crucial for understanding AD progression but remain challenging due to the lack of large-scale annotated datasets and the impact of staining variations on automated image analysis. Deep learning has emerged as a powerful tool for pathology image segmentation; however, model performance is significantly influenced by variations in staining characteristics, necessitating effective stain normalization and enhancement techniques. In this study, we address these challenges by introducing an open-source dataset (ADNP-15) of neuritic plaques (i.e., amyloid deposits combined with a crown of dystrophic tau-positive neurites) in human brain whole slide images. We establish a comprehensive benchmark by evaluating five widely adopted deep learning models across four stain normalization techniques, providing deeper insights into their influence on neuritic plaque segmentation. Additionally, we propose a novel image enhancement method that improves segmentation accuracy, particularly in complex tissue structures, by enhancing structural details and mitigating staining inconsistencies. Our experimental results demonstrate that this enhancement strategy significantly boosts model generalization and segmentation accuracy. All datasets and code are open-source, ensuring transparency and reproducibility while enabling further advancements in the field.

Gabriel Jimenez, Leopold Hebert-Stevens, Benoit Delatour et al.

In this study, we proposed and evaluated a graph-based framework to assess variations in Alzheimer's disease (AD) neuropathologies, focusing on classic (cAD) and rapid (rpAD) progression forms. Histopathological images are converted into tau-pathology-based (i.e., amyloid plaques and tau tangles) graphs, and derived metrics are used in a machine-learning classifier. This classifier incorporates SHAP value explainability to differentiate between cAD and rpAD. Furthermore, we tested graph neural networks (GNNs) to extract topological embeddings from the graphs and use them in classifying the progression forms of AD. The analysis demonstrated denser networks in rpAD and a distinctive impact on brain cortical layers: rpAD predominantly affects middle layers, whereas cAD influences both superficial and deep layers of the same cortical regions. These results suggest a unique neuropathological network organization for each AD variant.